semaglutide concerns Compounded is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Semaglutide Compounding Safety Concerns: 10
Description
As a result, SABAs are often used for short-acting intervals, such as a few hours, and have limited capabilities to prevent asthma exacerbations alone (4)
Compounded versions can be made in forms that are more palatable or easier to administer
Injection-site and systemic risks : Improper reconstitution or non-sterile technique can introduce bacteria or particulates into the solution, leading to localised infections, abscesses, or, in severe cases, systemic sepsis
Also, vials are sealed and labeled clearly with batch numbers
